International Health-Tech Program – Phase I
Open Date:
03/03/2025Deadline for Submission:
24/04/2025Time zone:
Israel
Summary:
The collaboration between Israeli medical technology companies and leading U.S. hospitals plays a crucial role in advancing global healthcare. Israeli med-tech firms bring cutting-edge innovations, agility, and a strong entrepreneurial spirit, while U.S. hospitals provide world-class clinical expertise, large-scale infrastructure, and access to diverse patient populations. This synergy accelerates the development and validation of groundbreaking medical technologies, from AI-driven diagnostics to life-saving devices, ultimately improving patient outcomes. By leveraging each other’s strengths, these partnerships drive medical breakthroughs, enhance treatment effectiveness, and shape the future of healthcare on an international scale.
Program Description
The programs are operating under the Israel Innovation Authority’s R&D Fund Incentive Program.
The goals of the collaboration are to stimulate transnational partnerships, accelerate the availability of medical innovations to the public, introduce Israeli healthcare technology to global markets, and advance the development of discoveries for the benefit of patients all over the world.
Funding
The Israel Innovation Authority will support of 20% to 50% of the approved R&D budget for 24 months of the Israeli companies, according to the funding regulations
Criteria
The Criteria and pre-conditions for evaluation are detailed in the Israel Innovation Authority’s R&D Fund Incentive Program
Application Process
- This announcement invites Israeli Companies to submit the EOI (Expression of Interest) application no later than April 24, 2025 at 12:00 (IST).
- Applicants are required to follow the local requirements and use the application format and instructions provided. Applications that are not in the approved format will not be accepted.
- Results will be sent after the committees on both sides make their decisions (if necessary).
- Companies submit the EOI (Expression of Interest), and after an initial screening, those that pass this stage will be invited to a virtual pitch day with the partners, which will take place on May 15, 2025 (the date might slightly change).
- During the pitch day, companies will present their projects to the partners. Subsequently, in June, a call in the health sector will be published, and companies will be able to submit a full application to the Innovation Authority until July 29, 2025.
- The application forms will be forwarded to the partners for the further selection process.